image

The best stocks to buy since 1993

Latest issue now available

Regenersis - forecasts upgraded 24% for current year

June 2008

Investing in shares may lose you all or some of your money. Past performance is no indication of future performance. Some of the shares recommended here may be small company shares, which can be relatively illiquid and hard to trade and this makes such shares more risky than other investments.

  • Epic Code:
  • RGS
  • Price:
  • 77p
Old timers can be forgiven for being somewhat baffled by why we are recommending Regenersis (not to be confused with the similarly sounding Regenesis which is an AIM listed penny share dreadful). Regenersis (RGS) is the amalgamation of two companies (CRC and Fonebak) that were individually quoted until last year. The group makes most of its money from the former CRC part, which carries out repairs to a variety of consumer electronic items such as mobile phones, set-top boxes, blackberries, ipods and computer equipment. Admittedly, if this was a once off repair it would be pretty unexciting but Regenersis is providing the service to electronic manufacturers as part of their warranty commitments. Conditions for RGS’ smaller arm ...

To access our archive of articles and to receive current issues you need to subscribe.

Subscribe now

Already a subscriber? Login

With small companies there is an above average degree of risk compared to buying blue chips. Please be aware that we have not assessed the suitability of any of these investments for you. The newsletter simply states a personal view and diarises the editor’s investment decisions. Please speak to your stockbroker or other qualified individual to ascertain whether any of these companies mentioned would form useful additions to your own portfolios. Past performance is no indication of future success.

All material on this website is protected by copyright. You may use Information retrieved from the www.scsw.co.uk website for your own personal non-commercial use which means that you may not sell or copy this information to any third party without prior written consent. ISSN 1358-183X

LIMITED PERIOD OFFER!

SUBSCRIBE TODAY AND SAVE £30 WITH OFFER CODE 30OFFSCSW

To access our archive of articles and to receive current issues you need to subscribe